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Fig. S1. Expression and activity of SHH are not impacted in Gas1-/- embryos during 
early neurulation. 
(A) SHH protein (magenta; left panels) as well as Shh (red; middle left panels) and Gli1 
transcripts (green; middle right panels) were co-detected on coronal sections from E8.5 
control or Gas1-/- embryos (8-9 and 10-11 somite stages) using immunohistology or 
fluorescence in situ hybridization (FISH), respectively. Both single and merged channel 
(right panels) configurations are shown for each section. Dotted lines demarcate prechordal
plate (PrCP) and rostral diencephalon ventral midline (RDVM). The inset (adapted from 
BioRender.com) illustrates the plane of section for all panels. n=3 embryos per somite stage 
and genotype. (B) Detection of Shh transcripts on coronal sections of E8.5 control and Gas1-/- 
embryos using FISH. Image magnified from panel (A). Dotted lines demarcate the PrCP. (C) 
The area of the Shh expression domain in the PrCP of control and Gas1-/- embryos at 8-9 and 
10-11 somites was quantified using FISH (as exemplified in B). Areas are given as mean 
values of 3-4 consecutive sections per embryo. No significant differences in PrCP area was 
seen comparing Gas1-/- and control embryos using unpaired t test. n=9-11 embryos per somite 
stage and genotype. Scale bars: 50 µm. 





















Fig. S2. Global RNA sequencing indicates dysregulated expression of SHH target genes 
in the rostral ventral forebrain midline of Gas1-/- embryos.  
RNA expression data for the indicated SHH target genes in the isolated rostral ventral 
forebrain midline of control and Gas1-/- embryos at E10.0 are shown. Levels are given as 
transcripts per million (TPM). n=5 (Control) and n=4 (Gas1-/-) samples of 5 embryos per 
replicate pool. Significant differences were determined using unpaired t-test. * p < 0.05,        
** p < 0.01, *** p < 0.001. 





















Fig. S3. Global RNA sequencing indicates dysregulated expression of NOTCH target 
genes in the rostral ventral forebrain midline of Gas1-/- embryos.  RNA expression data 
for the indicated NOTCH target genes in the isolated rostral ventral forebrain midline of 
control and Gas1-/- embryos at E10 are shown. Levels are given as transcripts per million 
(TPM). n=5 (Control) and n=4 (Gas1-/-) replicate pools with 5 embryos per pool. Significant 
differences were determined using unpaired t-test. * p < 0.05, ** p < 0.01. 





















Fig. S4. Gas1 deficiency does not impact NOTCH activity in the caudal neural tube. 
(A) Immunodetection of GAS1 protein (upper panel, red) and Gas1 transcripts (middle and 
lower panels, red) in the rostral neuroepithelium of control but not Gas1-/- embryos at the 
indicated stages of development. Nuclei are counterstained with DAPI. In the E8.5 image, 
dotted lines indicate the rostral neuroepithelium. (B) Detection of Notch1 (green; upper 
panels), Dll1 (magenta; middle panels), and Hes5 (red; lower panels) transcripts on coronal 
sections of E10.5 spinal cord using FISH. Transcript levels in Gas1-/- embryos are similar to 
those in controls. Scale bars: 50 µm. n=3 embryos per somite stage and genotype. Insets 
demonstrate plane of sections (adapted from BioRender.com). 










































Fig. S5. iPSC-derived neuroepithelial cells to model GAS1 function in the RDVM 
(A) CRISPR/Cas9 strategy for disrupting GAS1. Structural organization of human GAS1 
indicating the coding sequence targeted by the single guide (sg) RNA. Nucleotide numbers 
according to human GAS1 sequence NM_002048.3. PAM, protospacer adjacent motif. (B) 
Disruption of the GAS1 coding sequence by a 13 nucleotides long deletion in iPSC line 
GAS1KO. The respective wild-type GAS1 sequence is shown above (WT). (C) 
Immunofluorescence detection of pluripotency markers NANOG, OCT4 and SOX2 in WT 
and GAS1 KO iPSC lines. Nuclei were counterstained with DAPI. Scale bar: 50 µm. (D-F) 
qRT-PCR of relative transcript levels for NANOG (D), OCT4 (E), and SOX2 (F) in WT and 
GAS1 KO iPSCs. Levels in (D-F) are given as CT values normalized to transcript levels of 
GAPDH (2-DCT ± standard derivation (SD). No statistically significant differences were seen 
comparing genotypes (unpaired t test, n=3 biological replicates). (G-J) TaqMan Scorecard 
analysis of WT and GAS1 KO iPSCs and spontaneously differentiated embryoid bodies 
(EBs) after 14 days, respectively. (G) WT and GAS1 KO iPSCs and EBs showed similar 
scores for self-renewal, ectoderm, mesoderm and endoderm differentiation compared to the 
expression profile of the reference standard. EBs downregulated self-renewal genes indicated 
by (-), while upregulating ectoderm, mesoderm and endoderm genes as indicated by (+). (H, 
I) Correlation plots depict comparable expression rates of the 96 analyzed genes between 
iPSCs (H) and EBs (I) of different genotypes. Corresponding correlation coefficients (R2) are 
shown in the upper left corner. (J) Heatmaps of the analyzed genes related to self-renewal, 
mesendoderm, endoderm, mesoderm and ectoderm fate. Values and colors correlate to the 
fold changes (FC) of each gene relative to the undifferentiated reference set. 





















Fig. S6. GAS1 KO iPSCs fail to induce a SHH-dependent ventral neuroepithelial cell 
fate. 
(A) WT and GAS1 KO iPSCs (day 0), and day 5 NPCs derived thereof, were stained for 
multipotency marker OCT4 (red). (B) Immunodetection of PAX6 (red) in WT and GAS1 KO 
iPSCs at the indicated timepoints of neuroepithelial differentiation. The dorsal marker PAX6 
is downregulated in WT, but not in GAS1 KO NPCs, upon SHH-dependent ventral cell fate 
induction (panel day 11 ventral). (C) Immunodetection of NKX2.1 (red) in WT and GAS1 KO 
NPCs at day 11 of dorsal or ventral neuroepithelial differentiation. The ventral marker 
NKX2.1 is upregulated in WT, but not in GAS1 KO NPCs, upon SHH-induced ventralization. 
Nuclei in (A-C) were counterstained with DAPI. Scale bars: 25 µm. 





















Fig. S7. Loss of SHH signaling does not impact HES5 expression in NPCs. 
Relative transcript levels of HES5 were determined by qRT-PCR in NPCs at day 8-10 of 
differentiation. Cells had been treated overnight with control medium, or with medium 
containing 200 nM smoothened agonist (SAG) or SHH-Np, in the absence or presence of 
50 nM cyclopamine-KAAD (CKAAD). n=4 biological replicates per genotype and 
condition. Levels are given as CT values normalized to transcript levels of GAPDH (2-DCT ± 
standard derivation (SD). Statistical analyses were performed by two-way ANOVA with 
Bonferroni post hoc test. **** p < 0.0001. 





















Table S1. Expression values of differentially expressed genes related to the gene 
ontology term “smoothened signaling pathway” comparing Gas1-/- with control embryos 
MGI symbol log2 fold change q value 
Kif7 -8.515 3.794E-04 
Sin3a -7.752 7.008E-03 
Nme7 -5.377 3.881E-02 
Nkx2.2 -4.422 2.636E-03 
Hes5 -3.788 1.350E-02 
Ptch1 -1.957 4.501E-02 
Shh -1.825 8.659E-06 
Scube1 2.288 1.404E-10 
Fgf10 3.054 3.467E-16 
Table S2. Expression values of differentially expressed genes related to the gene 
ontology term “NOTCH signaling pathway” in Gas1-/- embryos as compared to controls 
MGI symbol log2 fold change q value 
Tcf3 -22.727 1.566E-09 
Sin3a -7.752 7.008E-03 
Traf7 -7.743 3.745E-07 
Hes5 -3.788 1.350E-02 
Dll1 -3.376 2.040E-05 
Mfng -2.859 6.735E-04 
Dll3 -2.619 4.743E-02 
Nrarp -2.011 1.851E-02 
Notch1 -1.694 4.825E-04 
Fat4 2.063 8.931E-09 
Fgf10 3.054 3.467E-16 
Tbx2 3.426 1.114E-05 
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SUPPLEMENTARY MATERIALS AND METHODS
In situ hybridization and immunohistology on mouse tissue 
The plasmid for generating the in situ hybridization (ISH) probe targeting Shh was kindly 
provided by A. P. McMahon (University of Southern California, Los Angeles). ISH probes 
detecting Hes5 and Nkx2.1 were generated in house targeting basepairs 573-1271 for Hes5 
(reference NM_010419.3) and basepairs 2032-2813 for Nkx2.1 (reference NM_009385.2). 
Immunofluorescence staining was carried out using rabbit anti-SHH (1:50, sc-9024, Santa 
Cruz Biotechnology) or goat anti-GAS1(1:50, AF2644, R&D Systems), respectively, and 
secondary antibodies conjugated with Alexa Fluor fluorophores (1:1000, Invitrogen). 
RNAscope fluorescent ISH (FISH) on 6 µm paraffin sections was performed according to 
manufacturer’s protocols using the Multiplex Fluorescent Reagent Kit v2 (ACD) with 
standard conditions for manual target retrieval and Protease Plus treatment. Following probes 
from ACD were used: Shh (3143661) or Shh-C2 (3143661-C2), Gli1 (311011) or Gli1-C2 
(311011-C2), Notch1-C2 (404641-C2), Dll1-C3 (425071-C3), Hes5 (400991) or Hes5-C2 
(400991-C2). Bound probes were visualized using Opal dyes 520 (FP1487001KT), 570 
(FP1488001KT) or 620 (FP1495001KT, all from Akoya Biosciences) at a dilution of 1:1500. 
Microdissection and bulk RNAseq 
For laser capture microdissection (LCM), E10.0 embryos (30-33 somites) were dissected on 
ice and fixed in 2% paraformaldehyde (PFA) for two hours at 4°C. After washing with PBS 
twice, embryos were infiltrated with 30% sucrose in PBS for two hours at 4°C, sequentially 
incubated with 25%, 50%, and 75% Tissue Tek O.C.T. compound (Sakura) in 30% sucrose 
solution for 30 minutes at 4°C each before embedding in Tissue Tek O.C.T. Coronal 12 µm 
cryosections were collected on membrane slides (MembraneSlide NF 1.0 PEN, 415190-





















9081-000, Zeiss), shortly washed in water, and dehydrated in cold 70% and 100% ethanol. 
Dried sections were stored in membrane slide chambers at -80°C. Before microdissection, 
slides were gradually chilled to room temperature (RT) by incubating at -20°C, 4°C, and RT 
for 20 minutes each. LCM was performed by using the Zeiss Axio Observer Z1. Dissected 
rostral ventral forebrain midlines were collected in AdhesiveCap 500 tubes (415190-9201-
000, Zeiss), directly lysed in RNA lysis buffer, shortly stored on dry ice, and then transferred 
to -80°C. For processing, samples were thawed on ice and RNA was isolated using the 
RNeasy FFPE Kit (Qiagen) according to the manufacturer’s manual. RNA integrity and yield 
were assessed using the Bioanalyzer 2100 (Agilent Technologies) and Qubit fluorometric 
quantification (Thermo Fisher Scientific), respectively. RNA with RNA integrity number 
(RIN) > 6.5 was used for cDNA library preparation using the SMARTer Stranded Total 
RNA-Seq Pico Kit (Takara), and libraries were sequenced in a 2 x 75 bp paired end run on an 
Illumina HiSeq 4000 system with 20 million reads per sample. The analysis involved five 
replicates for control and four replicates for Gas1-/- embryos. Each replicate consisted of a 
pool of five embryos of the respective genotype. 
Salmon v0.12.0 (Patro et al., 2017) was used to quantify the expression of transcripts 
against the Ensembl release 94 of the Mus musculus transcriptome. The multiple forms of 
noncoding RNA present in the total RNA sequencing were removed from the GTF file 
provided by the same Ensembl release. Only "protein_coding" and lincRNA transcript types 
were kept. Transcripts quantified by Salmon but not present in the filtered GTF file were 
removed for the downstream analysis. DESeq2 R package (Love et al., 2014) was used with 
default parameters to find the differentially expressed genes (DEGs). Transcripts with less 
than 5 read counts were filtered and p-values were corrected for multiple testing using the 
Benjamini-Hochberg procedure. DEGs recorded in at least two genotypic replicates were 
subjected to gene ontology (GO) term enrichment analysis using AmiGO (Carbon et al., 





















2009) and ConsensusPathDB (Kamburov et al., 2011; Kamburov et al., 2009), over-
representation analysis and default parameters, while only GO terms with q-value ≤ 0.05 
were considered. Heatmaps and PCA were generated using the heatmap.2 and prcomp 
function from the ggplot2 library in RStudio, respectively. 
The RNA-seq data have been deposited in the ArrayExpress database at EMBL-EBI under 
accession number E-MTAB-10207. 
Scorecard assay 
Pluripotency and the ability of generating all three germ layers were assessed by TaqMan 
Scorecard Assay (Applied Biosystems) on spontaneously differentiated embryoid bodies 
(EB) (Tsankov et al., 2015). For EB formation, iPSCs were dissociated with Accutase, 
seeded into Nucleon Sphera 96-well U-shaped-bottom plates (Thermo Fisher Scientific) at a 
density of 8000 cells/well in E8 medium supplemented with 10 µg/ml Y27632, and 
centrifuged for 3 minutes at 200 g. Next day, the medium was replaced by DMEM/F12 
supplemented with 10% KnockOut Serum Replacement and 1% penicillin-streptomycin 
(Gibco). The medium was changed every 3 days. iPSCs (day 0) and EBs (day 14, pool of 20 
EBs per genotype) were subjected to RNA isolation followed by cDNA reverse transcription 
using the RNeasy Mini (Qiagen) and High-Capacity RNA-to-cDNA Kit (Applied 
Biosystems), respectively, before performing the Scorecard assay according to the 
manufacturer’s protocols. Gene expression data were analyzed via the web-based hPSC 
Scorecard Analysis Software (Thermo Fisher Scientific). 
Generation of neural progenitor cells 
The protocol for differentiating WT and GAS1 KO cells into NPCs was published before 
(Flemming et al., 2020). Briefly, iPSCs were dissociated with Accutase and 20.000 cells/cm2





















were plated on Matrigel-coated plates in E8 medium supplemented with 10 µg/ml Y27632 
for 24 hours. Cells were allowed to grow for 3 days in E8 medium until they were nearly 
confluent, after which the medium was changed to N2B27 differentiation medium containing 
100 ng/ml noggin (6057-NG, R&D Systems), 200 nM dorsomorphin (sc-361173A, Santa 
Cruz Biotechnology) inhibiting BMP signaling and 10 µM SB431542 (Cay13031, Cayman 
Chemical) for the inhibition of TGFb signaling. The medium was changed daily. For ventral-
like NPC induction, the medium was replaced by N2B27 containing noggin, dorsomorphin, 
and 200 ng/ml SHH at day 5 of differentiation, and cells were grown for up to 6 more days.  
Immunofluorescence staining and immunohistology of iPSCs/NPCs 
Cells were washed with PBS to remove cell debris and fixed in 4% PFA for 15 minutes at 
RT. After washing with PBS, cells were permeabilized in blocking buffer containing 5% 
BSA and 0.5% Triton X100 for 1 hour at RT before incubating with primary antibodies 
diluted in blocking buffer at 4°C overnight. After washing in TBS with 1% Triton X-100 for 
30 minutes and subsequently in TBS with 0.1% Tween 20, cells were incubated with 
secondary antibodies conjugated with Alexa Fluor fluorophores (Invitrogen) diluted 1:1000 
in blocking buffer for 1-2 hours at RT. Cells were counterstained with DAPI and mounted 
with ProLong Gold Antifade Mountant (Life Technologies). Following primary antibodies 
were used: sheep anti-DLL1 (1:100, AF5026, R&D Systems), goat anti-GAS1 (1:50, 
AF2636, R&D Systems), goat anti-NANOG (1:100, AF1997, R&D Systems), rabbit anti-
NKX2.1 (1:40, MAB94581, R&D Systems), sheep anti-NOTCH1 (1:200, AF5267, R&D 
Systems), rabbit anti-PAX6 (1:200, 901301, BioLegend), rabbit anti-OCT4 (1:400, sc-5279, 
Santa Cruz Biotechnology) and rabbit anti-SOX2 (1:100, ab97959, Abcam).  
RNAscope FISH of HES5 transcripts was performed using the Multiplex Fluorescent 
Reagent Kit v2 (ACD) according to manufacturer’s protocol and the technical note 





















“RNAscope Assay for Adherent Cells Cultured on Coverslips”. Bound human HES5 probe 
(521391) was visualized using Opal dye 570 (FP1488001KT) at a dilution of 1:1000. 
Proximity ligation assay 
Proximity ligation assay (PLA) was performed according to the manufacturer’s instructions 
(Duolink PLA Fluorescence). PFA-fixed NPCs at differentiation day 7-9 were incubated with 
directly conjugated primary antibodies at a dilution of 1:100 generated with Duolink In Situ 
Probemaker PLUS and MINUS Kits. PLA signals were visualized using the Duolink In Situ 
Detection Reagent Kit Orange (all Sigma-Aldrich). Following primary antibodies were used: 
goat anti-GAS1 (AF2636, R&D Systems), sheep anti-NOTCH1 (AF5267, R&D Systems) 
and rabbi anti-PTCH1 (homemade). 
Quantitative real-time-PCR 
Total RNA was isolated using the RNeasy Mini Kit (Qiagen) according to the manufacturer’s 
instructions with additionally treating the samples with RNase-free DNAse I (Qiagen) for 15 
minutes at RT. One µg total RNA was reverse transcribed using the High-Capacity RNA-to-
cDNA Kit (Applied Biosystems). The resulting cDNA was amplified using TaqMan 
oligonucleotide probes and the TaqMan Gene Expression Master Mix on a 7900HT Fast Real 
time PCR System and the Sequence detection system V2.4 (all Applied Biosystems). Results 
were analyzed using the comparative cycle threshold (CT) method. TaqMan probes from 
Applied Biosystems were DLL1 (Hs00194509_m1), DLX2 (Hs00269993_m1), FOXG1 
(Hs01850784_s1), GAPDH (Hs02758991_g1), GAS1 (Hs00266715_s1), GLI1 
(Hs00171790_m1), GLI3 (Hs00609233_m1), HES5 (Hs01387463_g1), LHX6 
(Hs01030943_m1), NANOG (Hs02387400_g1), NKX2.1 (Hs00968940_m1), NKX2.2 





















(Hs00159616_m1), NOTCH1 (Hs01062014_m1), OCT4 (Hs00999632_g1), PAX6 
(Hs00240871_m1) and SOX2 (Hs01053049_s1). 
Co-immunoprecipitation 
NPCs were differentiated until day 6, seeded onto Matrigel-coated 6-well-plates at a density 
of 250000 cells/well, and transfected with pCIG-hGAS1-IRES-GFP (kindly provided by F. 
Charron, McGill University, Canada) using Lipofectamine2000 (Invitrogen) according to 
manufacturer’s protocol. 48 hours after transfection, cells were fixed in 1% formaldehyde 
(Thermo Fisher Scientific) for 5 minutes at RT and quenched with cold 1.25 M glycine. Co-
immunoprecipitation (Co-IP) was performed using the Pierce Crosslink Magnetic IP/Co-IP 
Kit (Thermo Fisher Scientific). For each reaction, 10 µg/ml goat anti-GAS1 antibody 
(AF2636, R&D Systems) or a non-immmune goat IgG control (01-6202, Invitrogen) were 
bound to 50 µl magnetic beads for 1 hour and crosslinked for 30 minutes. Cells were lysed 
with IP Lysis/Wash Buffer supplemented with cOmplete Protease Inhibitor Cocktail (Roche) 
for 1-2 hours on ice on a vertical shaker. The Pierce BCA Protein Assay Kit (Thermo Fisher 
Scientific) was used to determine protein concentration in cell lysates. Thirty µg protein 
lysate was used as input control and 200-300 µg protein lysate was incubated with 
crosslinked beads at 4°C overnight. Elution was performed for 30 minutes at RT on a rotator. 
Samples were incubated with Novex Tris-Glycine SDS Sample buffer (Invitrogen) 
supplemented with 2.5% 2-Mercaptoethanol for 5 minutes at 60°C, before subjecting to 
protein analysis by western blotting.  
Western blot analysis 
Protein expression in cells was evaluated by western blot analysis using standard procedures. 
Primary antibodies used for immunodetection were goat anti-GAS1 (1:500, AF2636, R&D 





















Systems), mouse anti-HA.11 (1:1000, 901513, BioLegend), rabbit anti-NOTCH1 (1:1000, 
4380, Cell Signaling Technology), rabbit anti-cleaved NOTCH1 (1:500, 4147, Cell Signaling 
Technology) and mouse anti-tubulin (1:1000, CP06, Calbiochem). Primary antibodies were 
detected using secondary antibodies conjugated with horseradish peroxidase (diluted 1:1500; 
Sigma-Aldrich) and SuperSignal West Femto Maximum Sensitivity Substrate (Thermo 
Fisher Scientific). Protein levels were quantified by densitometric scanning of western blots 
using the Odyssey Fc Imaging System and Image Studio Lite Software (LI-COR 
Biosciences). 
Lentivirus production 
For producing NICD or GFP overexpressing lentivirus particles, HEK293TN cells were 
cultivated on 0.0025% poly-L-Lysin (Sigma-Aldrich) coated culture flasks in Opti-MEM 
(Gibco). Cells were transfected with lentivirus envelope and packaging plasmids pMD2.D, 
pMDLg/pRRE and pRSV-Rev (Addgene plasmids #12259, #12251 and #12253, respectively, 
and the control plasmid EF.PGK.GFP (Addgene plasmid #17618) or the NICD expressing 
plasmid NOTCH1 intracellular domain-pcw107-V5 (Addgene plasmid #64622) using 
Lipofectamine2000 according to manufacturer’s instructions in Opti-MEM supplemented 
with 25 µM chloroquine (Sigma-Aldrich). After 6 hours, the medium was changed to Opti-
MEM supplemented with 10 µM sodium butyrate (Sigma-Aldrich). Cells were further 
cultivated for 2-3 days and the medium replaced and collected every day. The collected 
medium was centrifuged for 15 minutes at 500 g at 4°C to remove cell debris and every 3 
volumes of lentivirus containing supernatant was incubated with 1 volume of cold Lenti-X 
Concentrator (Clontech Laboratories) on ice at 4°C overnight. The mixture was centrifuged 
at 4°C for 45 minutes at 1500 g and lentiviral pellets were resuspended in 1:100 of the 
original volume using cold and sterile PBS. Lentiviral particle containing solutions were 
aliquoted and stored at -80°C.  
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